AllAnalyst Report
Morningstar•April 29, 2021
Morningstar•April 29, 2021West Pharmaceutical Services, Inc.: West Has Record Quarter and Raises Guidance; We're Above Top-Line Consensus, but Shares Look Pricey
Summary
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments
Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Actions
Download Full ReportRelated Reports
- RMD: Lowering target price to $194.00Apr 17, 2024 •
RMD
- AOS: Lowering target price to $90.00Apr 17, 2024 •
AOS
- TFX: Lowering target price to $221.00Apr 17, 2024 •
TFX
- EXPD: Lowering target price to $121.00Apr 17, 2024 •
EXPD
- BRO: Lowering target price to $85.00Apr 17, 2024 •
BRO
Analyst Profile
Aaron Degagne
Equity AnalystAaron DeGagne is an equity analyst, financial services, for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He contributes primarily to the research coverage of South American banks and Canadian insurance companies and conducts general research on the global financial-services sector.Before joining Morningstar in 2017, DeGagne was an accounting intern for Campgroup and completed two lending-group internships with RBC Capital Markets.DeGagne holds a Bachelor of Business Administration in finance from the University of Notre Dame’s Mendoza College of Business.